Citations 2
AN OPEN‐LABEL TRIAL OF ORAL CA‐4948 AN IRAK4 INHIBITOR COMBINED WITH IBRUTINIB IN ADULT PATIENTS WITH RELAPSED OR REFRACTORY HEMATOLOGIC MALIGNANCIES
Ramchandren, Radhakrishnan , Nowakowski, Grzegorz S. , Lunning, M., Mead, Monica , Martinez, Elizabeth , Roemeling, R. von, Leslie, Lori A. , Joffe, Erel , Rosenthal, Allison , Tun, Han W. , Lunning, Matthew A.
Hematological Oncology | June 17, 2021 | Volume: 39 | Issue: S2 | Pages: No page available
PHASE I/II STUDY OF CHOEP PLUS LENALIDOMIDE AS INITIAL THERAPY FOR PATIENTS WITH STAGE II‐IV PERIPHERAL T‐CELL NON‐HODGKIN LYMPHOMA: PHASE I RESULTS FROM THE T‐CELL CONSORTIUM
Lunning, M., Mehta–Shah, Neha , Moskowitz, Alison J. , Beaven, Anne , Haverkos, Bradley M. , Lechowicz, MaryJo, Oki, Yasuhiro , Ansell, Stephen M. , Lunning, Matthew A. , Horwitz, Steven M. , Advani, Ranjana H. , Zain, Jasmine
Hematological Oncology | June 7, 2017 | Volume: 35 | Issue: S2 | Pages: 411-412